Clinical study regarding the relationship between Lipoprotein (a) and C reactive protein serum levels in peripheral arterial disease

Farmacia

Volumn 57, Issue 1, 2009, Pages 43-51

  Nagy, Elod ^a   Oşan, Alexandrina ^a   Fekete, Timea ^a   Kósa, Katalin ^a   Póta, Sára ^a   Vitǎ, Ionel ^b   Kelemen, Piroska ^a   Puskás, Attila ^a  

^a UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b Institute of Cardiovascular Disease and Transplantation   (Romania)

Author keywords

C reactive protein; Critical ischaemia; Lp(a); Peripheral arterial disease (PAD)

Indexed keywords

BLOOD CLOTTING FACTOR 8; C REACTIVE PROTEIN; LIPOPROTEIN A;

ADULT; ANKLE BRACHIAL INDEX; ARTERIAL WALL THICKNESS; ARTERY DISEASE; ARTICLE; CAROTID ARTERY; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL;

EID: 62649157296     PISSN: 00148237     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Ariyo A. A., Thach C., Tracy R.: Lp (a) Lipoprotein, Vascular Disease, and Mortality in the Elderly, New England Journal of Medicine 2003, 349:2108-2115
2. Borth W., Changs V., Bishop P.et al.: Lipoprotein (a) is a Substrate for Factor XIIIa and Tissue Transglutaminase, The Journal of Biological Chemistry, 1991, 206/27: 18149-18153
3. Catalano M., Cortelazzo A., Yilmaz Y.: The LPA gene C93T polymorphism influences plasma lipoprotein (a) levels and is-independently associated with susceptibility to peripheral arterial disease, Clinica Chimica Acta 2008 Jan, 387(1-2):109-12
4. Danesh J., Collins R., Peto R.: Lipoprotein (a) and coronary artery disease - meta-analysis of prospective studies, Circulation 2000, 102: 1082-1085
5. Dieplinger B, Lingenhel A, Baumgartner N.: Increased serum lipoprotein (a) concentrations and low molecular weight phenotypes of apolipoprotein (a) are associated with symptomatic peripheral arterial disease, Clinical Chemistry 2007 Jul, 53(7):1298-305
6. Hartmann M., Von Birgelen C., Erbel R. et al: Relation Between Lipoprotein (a) and Fibrinogen and Serial Intravascular Ultrasound Plaque Progression in Left Main Coronary Arteries, Journal of American College of Cardiology, 2006, 48/3: 446-452
7. Hoover-Plow J.: Elusive proatherothrombotic role of Lp (a): a new direction? Journal of Thrombosis and Haemostasis 2006, 4/5: 971-976
8. Romanic M., Arleth A. J., Ohlstein E. H. et al.: Factor XIIIa Cross-links Lipoprotein A with Fibrinogen and is Present in Human Atherosclerotic Lesions Circulation Research. 1998, 83:264-269
9. Nagy E., Fulop I., Harsfalvi J. et al.: Von Willebrand, fibrinogen, plasma peroxides and functional tests for peripheral ischaemia, Clinical Chemistry and Laboratory Medicine 2007, 45, pp.S1-S473, T094
10. Shai I., Rimm. B.E., Ma J. et al.: Lipoprotein (a) and coronary heart disease among women: beyond a cholesterol carrier, European Heart Journal 2005, 26:1633-1639
11. Tseng C.-H.: Lipoprotein (a) Is an Independent Risk Factor for Peripheral Arterial Disease in Chinese Type 2 Diabetic Patients in Taiwan, Diabetes Care 2004, 27:517-521
12. Undas A., Stepien E., Szczeklik A. et al.: Lipoprotein (a) as a modifier of fibrin clot permeability and Susceptibility to lysis, Journal of Thrombosis and Haemostasis 2006, 4/5: 973-979
13. Xing J.L., Boonmark N.W., Lawn R.M, et al: Fibrinogen deficiency reduces vascular accumulation of apolipoprotein (a) and development of atherosclerosis in apolipoprotein (a) transgenic mice, PNAS 1998, 95: 12591-12595
14. Yazici M., Demircan S., Durna K. et al.: Lipoprotein (a) levels in patients with unstable angina and their relationship with atherothrombosis and myocardial damage, International Journal of Clinical Practice 2005 Feb;59(i):150-5.